Aspire Biopharma Holdings Inc is a PR-based company operating in Pharmaceuticals industry. Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
ASBP stock price ended at $1.43 on 星期五, after rising 9.16%
On the latest trading day Feb 13, 2026, the stock price of ASBP rose by 9.16%, climbing from $1.29 to $1.43. During the session, the stock saw a volatility of 16.28%, with prices oscillating between a daily low of $1.29 and a high of $1.50. Notably, trading volume dropped by 45.1K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 472.7K shares were traded, equating to a market value of approximately $153.6M.